Events

Seminar on the research project Trajectories and health service use in individuals receiving gender incongruence treatments

The Centre for Population Health (Senter for populasjonshelse) at Haukeland University Hospital invites you to an academic seminar in connection with the research project "Trajectories and health service use in individuals receiving gender incongruence treatments". 

About the project

The project is a registry-based study funded by Helse Vest, examining long-term outcomes and patterns of health service use in individuals who have received treatment for gender incongruence in Norway. By linking national health and population registries, the project aims to describe trajectories over time and to provide an empirical basis for further clinical and policy discussions. The study is conducted in collaboration with the four regional centres for gender incongruence (RSKi), the National Treatment Service for Gender Incongruence (NBTK) at Rikshospitalet, the Norwegian Institute of Public Health (FHI), and King's College London, together with user organisations.

Purpose of the seminar

The aim of the meeting is transparency in research. We also wish to contribute to user involvement (brukermedvirkning). A central ambition is that researchers, clinicians and user organisations align on the relevant research questions and methods before the results are known.

To place the project in an international context, we have invited external researchers, including Dr Hilary Cass and Professor Eóin Killackey, who will contribute perspectives from work conducted abroad.

This is not a general seminar on research into gender incongruence. It is specific to this project.

Recording

The event will be audio- and video-recorded, and the recordings may be distributed in the public interest. Only persons on stage will be filmed.

Programme

• Welcome and context for the meeting
• The Norwegian context for gender-affirming treatment
• Dr Hilary Cass presents The Cass Review, which concluded that the evidence base for puberty blockers in gender-affirming treatment is weak. The review had immediate implications for clinical services in the United Kingdom, and similar evidence reviews followed in other countries.
• Eirik Stangeland Håheim: After Cass, and what is an evidence hierarchy?
• Professor Emily Simonoff (King's College London) presents the ongoing PATHWAYS trial on puberty blockers (https://www.kcl.ac.uk/research/pathways)
• Professor Eóin Killackey: international perspectives on the field [topic to be confirmed]
• Lise Gulli Brokjøb: examples of comparable registry-based studies
• Arnstein Mykletun: presentation of our project, including project description and variables, and the ambition to agree on research questions and methods before the results are known
• Contributions from other academics and clinicians in the field
• Invited comments on the project from collaborating partners (user organisations)
• Invited comments from clinical collaborating partners